134 related articles for article (PubMed ID: 34570739)
1. Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Cost Analysis.
Haase DR; Kimbrel B; Bombardier B; Templeton KJ; Rosenthal HG; Sweeney KR
J Am Acad Orthop Surg; 2021 Nov; 29(22):961-969. PubMed ID: 34570739
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review.
Haase DR; Templeton KJ; Rosenthal HG; Sweeney KR
J Am Acad Orthop Surg; 2020 Mar; 28(6):248-255. PubMed ID: 32142488
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid improves early postoperative mobilization in cancer patients undergoing endoprosthetic reconstruction.
Haase DR; Mersereau EJ; Kimbrel B; Bombardier B; Templeton KJ; Rosenthal HG; Sweeney KR
J Surg Oncol; 2022 Jun; 125(8):1318-1325. PubMed ID: 35213732
[TBL] [Abstract][Full Text] [Related]
4. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
[TBL] [Abstract][Full Text] [Related]
6. Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty.
George DA; Sarraf KM; Nwaboku H
Eur J Orthop Surg Traumatol; 2015 Jan; 25(1):129-33. PubMed ID: 24756178
[TBL] [Abstract][Full Text] [Related]
7. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Tranexamic Acid in Resection and Endoprosthetic Reconstruction of Distal Femoral Osteosarcomas in Children: A Retrospective Cohort Study.
Sofulu O; Ozturk O; Polat M; Buyuktopcu O; Kesimer MD; Erol B
J Pediatr Orthop; 2021 Sep; 41(8):e686-e691. PubMed ID: 34231541
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid for reducing blood transfusions in arthroplasty interventions: a cost-effective practice.
Vigna-Taglianti F; Basso L; Rolfo P; Brambilla R; Vaccari F; Lanci G; Russo R
Eur J Orthop Surg Traumatol; 2014 May; 24(4):545-51. PubMed ID: 23633085
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological reduction of bleeding during hip endoprosthetic replacement].
de Jonge T
Orv Hetil; 2012 Oct; 153(41):1607-12. PubMed ID: 23045310
[TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid: optimal blood loss management in surface replacement arthroplasty.
Sassoon A; Nam D; Jackups R; Johnson SR; Nunley RM; Barrack RL
Bone Joint J; 2016 Feb; 98-B(2):173-8. PubMed ID: 26850421
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of Efficacy of Systemic Administration of Tranexamic Acid (Exacyl) in Total Hip and Knee Arthroplasty - Prospective Cohort Study].
Mannová J; Kubát P; Pospíchal M; Longin P
Acta Chir Orthop Traumatol Cech; 2019; 86(2):118-123. PubMed ID: 31070570
[TBL] [Abstract][Full Text] [Related]
14. Effect of Tranexamic Acid on Transfusion Rates Following Total Joint Arthroplasty: A Cost and Comparative Effectiveness Analysis.
Evangelista PJ; Aversano MW; Koli E; Hutzler L; Inneh I; Bosco J; Iorio R
Orthop Clin North Am; 2017 Apr; 48(2):109-115. PubMed ID: 28336035
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic versus aminocaproic acids in patients with total hip arthroplasty: a retrospective study.
Xie H; Yang YS; Tian SM; Wang BJ; Fu WM; Cheng LL; Jiang NN; Gu G; Zhao DW
BMC Musculoskelet Disord; 2022 Nov; 23(1):999. PubMed ID: 36401231
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic Acid Safely Reduced Blood Loss in Hemi- and Total Hip Arthroplasty for Acute Femoral Neck Fracture: A Randomized Clinical Trial.
Watts CD; Houdek MT; Sems SA; Cross WW; Pagnano MW
J Orthop Trauma; 2017 Jul; 31(7):345-351. PubMed ID: 28633147
[TBL] [Abstract][Full Text] [Related]
17. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty.
Tuttle JR; Ritterman SA; Cassidy DB; Anazonwu WA; Froehlich JA; Rubin LE
J Arthroplasty; 2014 Aug; 29(8):1512-5. PubMed ID: 24630599
[TBL] [Abstract][Full Text] [Related]
18. Comparing ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee Arthroplasty.
Churchill JL; Puca KE; Meyer E; Carleton M; Anderson MJ
J Knee Surg; 2017 Jun; 30(5):460-466. PubMed ID: 27699724
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Combined with Topical Administration of Tranexamic Acid in Primary Total Hip Arthroplasty: A Randomized Controlled Trial.
Zeng Y; Si HB; Shen B; Yang J; Zhou ZK; Kang PD; Pei FX
Orthop Surg; 2017 May; 9(2):174-179. PubMed ID: 28093896
[TBL] [Abstract][Full Text] [Related]
20. Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: A randomized clinical trial.
Wu Y; Zeng Y; Hu Q; Li M; Bao X; Zhong J; Shen B
Thromb Res; 2018 Nov; 171():143-148. PubMed ID: 30312799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
